• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HOPX通过靶向SNAIL调节肝细胞癌的侵袭和迁移能力。

HOPX regulates the invasion and migration abilities of hepatocellular carcinoma by targeting SNAIL.

作者信息

Wang Rong, Xu Haizhou, Hu Changhuan, Chen Kun, Tang Shaowen, Wu Xiaoli, Zhang Qing, Xiang Qingfeng

机构信息

Department of Gastrointestinal Surgery, The Affiliated Qingyuan Hospital (Qingyuan People' Hospital), Guangzhou Medical University, Qingyuan, 511500, China.

Department of General Surgery, The first People's Hospital of Xiaogan, Xiaogan, 432000, China.

出版信息

Sci Rep. 2025 Aug 13;15(1):29739. doi: 10.1038/s41598-025-15581-w.

DOI:10.1038/s41598-025-15581-w
PMID:40804282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12350657/
Abstract

HOPX acts as a tumor suppressor in certain cancers, but the function of HOPX, as well as its mechanism of action in hepatocellular carcinoma (HCC) has not been fully elucidated. In this study, using in vitro and in vivo animal models, the effect of HOPX on the development of HCC was explored. In our study, the HOPX expression at both protein and mRNA level were found to be downregulated in HCC cells and tumor tissues. Restoration of HOPX expression was found to inhibit HCC cell invasion and migration capabilities, but produced no effect on growth. Moreover, HOPX prevented metastasis in an HCC cell metastatic mouse model. Further investigations showed that HOPX could suppress HCC cell epithelial-to-mesenchymal transition (EMT) by inhibiting SNAIL, an EMT transcription factor that is required for the metastasis-inhibition activity of HOPX to proceed. Our study identified HOPX as a suppressor of the development of HCC, which implies that HOPX suppresses HCC cells invasion and migration by inhibiting SNAIL.

摘要

HOPX在某些癌症中作为一种肿瘤抑制因子发挥作用,但其在肝细胞癌(HCC)中的功能及其作用机制尚未完全阐明。在本研究中,使用体外和体内动物模型,探讨了HOPX对HCC发生发展的影响。在我们的研究中,发现HCC细胞和肿瘤组织中HOPX的蛋白质和mRNA水平均下调。恢复HOPX表达可抑制HCC细胞的侵袭和迁移能力,但对生长无影响。此外,HOPX在HCC细胞转移小鼠模型中可预防转移。进一步研究表明,HOPX可通过抑制SNAIL来抑制HCC细胞上皮-间质转化(EMT),SNAIL是一种EMT转录因子,是HOPX转移抑制活性所必需的。我们的研究确定HOPX是HCC发生发展的抑制因子,这意味着HOPX通过抑制SNAIL来抑制HCC细胞的侵袭和迁移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/78858f3c5d75/41598_2025_15581_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/048ec785aa0e/41598_2025_15581_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/1bc341883f1c/41598_2025_15581_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/c31565d4f49a/41598_2025_15581_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/7213a3185b8a/41598_2025_15581_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/ff7cdfa34b21/41598_2025_15581_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/08116233523f/41598_2025_15581_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/78858f3c5d75/41598_2025_15581_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/048ec785aa0e/41598_2025_15581_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/1bc341883f1c/41598_2025_15581_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/c31565d4f49a/41598_2025_15581_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/7213a3185b8a/41598_2025_15581_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/ff7cdfa34b21/41598_2025_15581_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/08116233523f/41598_2025_15581_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5726/12350657/78858f3c5d75/41598_2025_15581_Fig7_HTML.jpg

相似文献

1
HOPX regulates the invasion and migration abilities of hepatocellular carcinoma by targeting SNAIL.HOPX通过靶向SNAIL调节肝细胞癌的侵袭和迁移能力。
Sci Rep. 2025 Aug 13;15(1):29739. doi: 10.1038/s41598-025-15581-w.
2
FBXW8-mediated degradation of PPT1 suppresses epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.FBXW8介导的PPT1降解抑制肝细胞癌的上皮-间质转化和转移。
Biochim Biophys Acta Mol Basis Dis. 2025 Oct;1871(7):167985. doi: 10.1016/j.bbadis.2025.167985. Epub 2025 Jul 12.
3
Opposing mechanisms by which miRNAs mediate distinct Nrf1 and Nrf2 regulation of epithelial-mesenchymal transition in hepatocellular carcinoma.微小RNA介导肝细胞癌上皮-间质转化中不同的Nrf1和Nrf2调控的相反机制。
RNA Biol. 2025 Dec;22(1):1-21. doi: 10.1080/15476286.2025.2548628. Epub 2025 Aug 21.
4
Transcriptional regulation of ATOX1 by PRRX2 impacts the progression and cuproptosis of hepatocellular carcinoma.PRRX2对ATOX1的转录调控影响肝细胞癌的进展和铜死亡。
Cell Signal. 2025 Oct;134:111883. doi: 10.1016/j.cellsig.2025.111883. Epub 2025 May 18.
5
Long non-coding RNA LNC-POTEM-4 promotes HCC progression via the LNC-POTEM-4/miR-149-5p/Wnt4 signaling axis.长非编码 RNA LNC-POTEM-4 通过 LNC-POTEM-4/miR-149-5p/Wnt4 信号轴促进 HCC 进展。
Cell Signal. 2024 Dec;124:111412. doi: 10.1016/j.cellsig.2024.111412. Epub 2024 Sep 13.
6
Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression.长链非编码RNA UCA1通过miR-203调控Snail2的表达以促进肝细胞癌进展。
J Cancer Res Clin Oncol. 2017 Jun;143(6):981-990. doi: 10.1007/s00432-017-2370-1. Epub 2017 Mar 8.
7
CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.CXCR2/CXCL5轴通过激活PI3K/Akt/GSK-3β/Snail信号通路促进肝癌细胞的上皮-间质转化。
Cancer Lett. 2015 Mar 28;358(2):124-135. doi: 10.1016/j.canlet.2014.11.044. Epub 2014 Nov 24.
8
Cytidine deaminase enhances liver cancer invasion by modulating epithelial-mesenchymal transition via NFκB signaling.胞苷脱氨酶通过NFκB信号通路调节上皮-间质转化来增强肝癌侵袭。
Biomed J. 2024 Sep 19;48(4):100789. doi: 10.1016/j.bj.2024.100789.
9
High glucose facilitates hepatocellular carcinoma cell proliferation and invasion via WTAP-mediated HK2 mRNA stability.高糖通过WTAP介导的HK2 mRNA稳定性促进肝癌细胞增殖和侵袭。
Mol Cell Biochem. 2025 Mar 3. doi: 10.1007/s11010-025-05235-w.
10
Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma.沉默GP73通过抑制肝细胞癌上皮-间质转化来抑制侵袭和转移。
Oncol Rep. 2017 Feb;37(2):1182-1188. doi: 10.3892/or.2017.5351. Epub 2017 Jan 4.

本文引用的文献

1
Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI).2018年胃肠道癌症研讨会(美国临床肿瘤学会胃肠道肿瘤研讨会)关于肝细胞癌的最新进展
J Hepatocell Carcinoma. 2018 Oct 3;5:87-90. doi: 10.2147/JHC.S171396. eCollection 2018.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
HOPX functions as a tumour suppressor in head and neck cancer.
HOPX 在头颈部癌症中作为一种肿瘤抑制因子发挥作用。
Sci Rep. 2016 Dec 9;6:38758. doi: 10.1038/srep38758.
4
Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer.HOPX的表观遗传沉默促进乳腺癌的侵袭性。
Cancer Lett. 2017 Jan 1;384:70-78. doi: 10.1016/j.canlet.2016.10.017. Epub 2016 Oct 15.
5
HOPX: The Unusual Homeodomain-Containing Protein.HOPX:一种不同寻常的含同源结构域蛋白。
J Invest Dermatol. 2016 May;136(5):905-911. doi: 10.1016/j.jid.2016.01.032. Epub 2016 Mar 23.
6
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.上皮-间质转化并非肺转移所必需,但会导致化疗耐药。
Nature. 2015 Nov 26;527(7579):472-6. doi: 10.1038/nature15748. Epub 2015 Nov 11.
7
EMT or EMT-Promoting Transcription Factors, Where to Focus the Light?上皮-间质转化或促进上皮-间质转化的转录因子,应将目光聚焦于何处?
Front Oncol. 2014 Dec 16;4:353. doi: 10.3389/fonc.2014.00353. eCollection 2014.
8
Regulation of the protein stability of EMT transcription factors.EMT 转录因子的蛋白质稳定性调控。
Cell Adh Migr. 2014;8(4):418-28. doi: 10.4161/19336918.2014.969998.
9
Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2.蜗牛蛋白部分通过激活核内细胞外信号调节激酶2促进乳腺癌细胞的上皮-间质转化。
PLoS One. 2014 Aug 14;9(8):e104987. doi: 10.1371/journal.pone.0104987. eCollection 2014.
10
Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein.卡博替尼通过调节P-糖蛋白的功能逆转人肝癌HepG2/adr细胞的多药耐药性。
Liver Int. 2015 Mar;35(3):1010-23. doi: 10.1111/liv.12524. Epub 2014 Apr 2.